ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,560 | -23.1% | 7,393 | -0.6% | 0.00% | – |
| Q2 2023 | $342,930 | +42.8% | 7,434 | +24.1% | 0.00% | – |
| Q1 2023 | $240,119 | -11.6% | 5,988 | +2.2% | 0.00% | – |
| Q4 2022 | $271,540 | -15.9% | 5,861 | +8.3% | 0.00% | – |
| Q2 2022 | $323,000 | -17.8% | 5,412 | +0.1% | 0.00% | – |
| Q1 2022 | $393,000 | +58.5% | 5,409 | +83.2% | 0.00% | – |
| Q4 2021 | $248,000 | +13.8% | 2,952 | +22.2% | 0.00% | – |
| Q3 2021 | $218,000 | -4.4% | 2,415 | +0.9% | 0.00% | – |
| Q2 2021 | $228,000 | -25.2% | 2,393 | -10.8% | 0.00% | – |
| Q1 2021 | $305,000 | -17.3% | 2,682 | +0.6% | 0.00% | – |
| Q4 2020 | $369,000 | – | 2,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |